Nutex Health (NASDAQ:NUTX) Shares Down 14% – Should You Sell?

Nutex Health Inc. (NASDAQ:NUTX)’s share price was down 14% on Wednesday . The stock traded as low as $142.00 and last traded at $132.8350. Approximately 32,740 shares changed hands during trading, a decline of 80% from the average daily volume of 166,585 shares. The stock had previously closed at $154.47.

Analysts Set New Price Targets

Several equities analysts have commented on NUTX shares. Weiss Ratings restated a “hold (c)” rating on shares of Nutex Health in a research note on Monday, December 29th. Wall Street Zen raised shares of Nutex Health from a “buy” rating to a “strong-buy” rating in a report on Friday, November 28th. Two research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $252.50.

Nutex Health Trading Down 15.9%

The company’s fifty day moving average price is $161.28 and its 200-day moving average price is $123.06. The stock has a market cap of $918.22 million, a price-to-earnings ratio of 7.06 and a beta of -0.01. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.20 and a quick ratio of 3.18.

Nutex Health (NASDAQ:NUTX) last released its earnings results on Tuesday, November 18th. The company reported $7.76 earnings per share for the quarter, topping the consensus estimate of ($5.43) by $13.19. The company had revenue of $243.99 million for the quarter, compared to the consensus estimate of $221.93 million. Nutex Health had a net margin of 11.62% and a return on equity of 37.44%.

Insider Buying and Selling

In other news, CFO Jon Christian Bates purchased 750 shares of the stock in a transaction on Tuesday, November 25th. The stock was bought at an average price of $136.71 per share, with a total value of $102,532.50. Following the transaction, the chief financial officer owned 5,638 shares in the company, valued at $770,770.98. The trade was a 15.34% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 36.92% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the company. BNP Paribas Financial Markets boosted its position in Nutex Health by 966.7% in the second quarter. BNP Paribas Financial Markets now owns 320 shares of the company’s stock valued at $40,000 after buying an additional 290 shares during the last quarter. State of Alaska Department of Revenue purchased a new stake in shares of Nutex Health in the 3rd quarter valued at $30,000. Ameritas Investment Partners Inc. acquired a new stake in shares of Nutex Health in the second quarter worth $44,000. KLP Kapitalforvaltning AS increased its stake in shares of Nutex Health by 66.7% in the third quarter. KLP Kapitalforvaltning AS now owns 1,500 shares of the company’s stock worth $155,000 after acquiring an additional 600 shares during the period. Finally, Police & Firemen s Retirement System of New Jersey purchased a new position in shares of Nutex Health during the second quarter worth $97,000. 5.32% of the stock is currently owned by hedge funds and other institutional investors.

About Nutex Health

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.